BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hingorani M, Dixit S, Johnson M, Plested V, Alty K, Colley P, Beavis AW, Roy R, Maraveyas A. Palliative Radiotherapy in the Presence of Well-Controlled Metastatic Disease after Initial Chemotherapy May Prolong Survival in Patients with Metastatic Esophageal and Gastric Cancer. Cancer Res Treat 2015;47:706-17. [PMID: 25687854 DOI: 10.4143/crt.2014.174] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Tang X, Zhou X, Li Y, Tian X, Wang Y, Huang M, Ren L, Zhou L, Ding Z, Zhu J, Xu Y, Peng F, Wang J, Lu Y, Gong Y. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study. Ann Surg Oncol 2019;26:321-8. [DOI: 10.1245/s10434-018-6929-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
2 Wu SG, He ZY, Wang Y, Sun JY, Lin HX, Su GQ, Li Q. Lymph node dissection improved survival in patients with metastatic thoracic esophageal cancer: An analysis of 220 patients from the SEER database. Int J Surg 2016;35:13-8. [PMID: 27613123 DOI: 10.1016/j.ijsu.2016.09.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
3 Chen Y, Cheng X, Song H, Wu AJ, Ku GY, Lee P, Slingerland M, Koyanagi K, Ke S, Qiu H, Shi W, Gao Y, Chen J; written on behalf of AME Radiation Oncology Collaborative Group. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for esophageal squamous cell cancer patients presenting with oligometastases. J Thorac Dis 2019;11:1536-45. [PMID: 31179097 DOI: 10.21037/jtd.2019.03.10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
4 Guttmann DM, Mitra N, Bekelman J, Metz JM, Plastaras J, Feng W, Swisher-McClure S. Improved Overall Survival with Aggressive Primary Tumor Radiotherapy for Patients with Metastatic Esophageal Cancer. J Thorac Oncol 2017;12:1131-42. [PMID: 28461255 DOI: 10.1016/j.jtho.2017.03.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
5 Shao C, Duan C, Wang J, Luan S, Gao Y, Jin D, Wang D, Li Y, Xu L. Expression of microtubule-associated protein TPX2 in human gastric carcinoma and its prognostic significance. Cancer Cell Int 2016;16:79. [PMID: 27777511 DOI: 10.1186/s12935-016-0357-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang S, Guo J, Zhang H, Li H, Hassan MOO, Zhang L. Metastasis pattern and prognosis in men with esophageal cancer patients: A SEER-based study. Medicine (Baltimore) 2021;100:e26496. [PMID: 34160464 DOI: 10.1097/MD.0000000000026496] [Reference Citation Analysis]
7 Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach. J Gastric Cancer 2019;19:1-48. [PMID: 30944757 DOI: 10.5230/jgc.2019.19.e8] [Cited by in Crossref: 103] [Cited by in F6Publishing: 106] [Article Influence: 34.3] [Reference Citation Analysis]
8 Wu SG, Zhang WW, He ZY, Sun JY, Chen YX, Guo L. Sites of metastasis and overall survival in esophageal cancer: a population-based study. Cancer Manag Res. 2017;9:781-788. [PMID: 29255373 DOI: 10.2147/cmar.s150350] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
9 Dong HM, Wang Q, Wang WL, Wang G, Li XK, Li GD, Chen J. A clinical analysis of systemic chemotherapy combined with radiotherapy for advanced gastric cancer. Medicine (Baltimore) 2018;97:e10786. [PMID: 29879015 DOI: 10.1097/MD.0000000000010786] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kawamoto T, Nihei K, Sasai K, Karasawa K. Palliative radiotherapy and chemoradiotherapy in stage IVA/B esophageal cancer patients with dysphagia. Int J Clin Oncol 2018;23:1076-83. [PMID: 30066207 DOI: 10.1007/s10147-018-1324-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]